Abstract
The increased toxicity of metabolic intermediates or metabolites is primarily the results of the conversion of xenobiotics into chemically reactive species such as reactive oxygen/nitrogen species, free radicals, or positively or neutral charged electrophiles. Electrophilic intermediates are consisted of nonionic and cationic species. Nonionic electrophilic intermediates are such as aldehydes, ketones, epoxides, quinones, sulfoxides, nitroso compounds, and acyl halides, while cationic electrophilic intermediates include carbonium ions and nitrenium ions. Chemically reactive species can interact with proteins, DNA, and lipids, leading to protein adducts, DNA adducts, and lipid peroxidation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Amacher DE (2006) Reactive intermediates and the pathogenesis of adverse drug reactions: the toxicology perspective. Curr Drug Metab 7:219–229
Anders MW (2007) Chemical toxicology of reactive intermediates formed by the glutathione-dependent bioactivation of halogen-containing compounds. Chem Res Toxicol 21:145–159
Anders MW (1985) Bioactivation of foreign compounds. Academic, New York
Anderson D (2001) Genetic and reproductive toxicity of butadiene and isoprene. Chem Biol Interact 135–136:65–80
Baird WM, Hooven LA, Mahadevan B (2005) Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ Mol Mutagen 45:106–114
Boelsterli UA (2007) Mechanistic toxicology. CRC Press, Boca Raton
Boelsterli UA, Ho HK, Zhou S, Leow KY (2006) Bioactivation and hepatotoxicity of nitroaromatic drugs. Curr Drug Metab 7(7):715–727
Bogdanffy MS, Taylor ML (1993) Kinetics of nasal carboxylesterase-mediated metabolism of vinyl acetate. Drug Metab Dispos 21:1107–1111
Bolton JL (2002) Quinoids, quinoid radicals, and phenoxyl radicals formed from estrogens and antiestrogens. Toxicology 177(1):55–65
Boyd JA, Eling TE (1987) Prostaglandin H synthase-catalyzed metabolism and DNA binding of 2-naphthylamine. Cancer Res 47(15):4007–4014
Chandrasekara A, Shahidi F (2011) Inhibitory activities of soluble and bound millet seed phenolics on free radicals and reactive oxygen species. J Agric Food Chem 59:428–436
Chen CH (2012) Activation and detoxification enzymes: functions and implications. Springer, New York
Dekant W, Vamvakas S (1993) Glutathione-dependent bioactivation of xenobiotics. Xenobiotica 23:873–887
Dietz BM, Bolton JL (2011) Biological reactive intermediates (BRIs) formed from botanical dietary supplements. Chem Biol Interact 192:72–80
Eaton DL, Gallagher EP (1994) Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 34:135–172
Furst SM, Uetrecht JP (1995) The effect of carbamazepine and its reactive metabolite, 9-acridine carboxaldehyde, on immune cell function in vitro. Int J Immunopharmacol 17(5):445–452
Glatt H (2000) Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 129:141–170
Guengerich FP (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611–650
Hinson JA, Forkert PG (1995) Phase II enzymes and bioactivation. Can J Physiol Pharmacol 73:1407–1413
James LP, Capparelli EV, Simpson PM et al (2008) Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther 84:684–690
Jinsmaa Y, Florang VR, Rees JN, Mexas LM, Eckert LL, Allen EM, Anderson DG, Doorn JA (2011) Dopamine-derived biological reactive intermediates and protein modifications: implications for Parkinson’s disease. Chem Biol Interact 192(1-2):118–121
Johnson WW (2008) Many drugs and phytochemicals can be activated to biological reactive intermediates. Curr Drug Metab 9(4):344–351
Kalgutkar AS, Dalvie DK, O’Donnell JP et al (2002) On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics. Curr Drug Metab 3:379–424
Khojasteh SC, Hartley DP, Ford KA, Uppal H, Oishi S, Nelson SD (2012) Characterization of rat liver proteins adducted by reactive metabolites of menthofuran. Chem Res Toxicol 25(11):2301–2309
Kim SY, Suzuki N, Laxmi YR et al (2004) Genotoxic mechanism of tamoxifen in developing endometrial cancer. Drug Metab Rev 36:199–218
Khojasteh SC, Hartley DP, Ford KA, Uppal H, Oishi S, Nelson SD (2012) Characterization of rat liver proteins adducted by reactive metabolites of menthofuran. Chem Res Toxicol 25(11):2301–2309
Koob M, Dekant W (1991) Bioactivation of xenobiotics by formation of toxic glutathione conjugates. Chem Biol Interact 77:107–136
Korobkova EA, Nemeth J, Cadougan M, Venkatratnam A, Bassit M, Azar N (2012) Reactive metabolites of desipramine and clomipramine: the kinetics of formation and reactivity with DNA. Bioorg Med Chem 20(1):340–345
Levi PE, Hodgson E (2008) Reactive metabolites and toxicity. In: Smart RC, Hodgson E (eds) Molecular and biochemical toxicology. Wiley, New York
Mao J, Dai W, Zhang S, Sun L, Wang H, Gao Y, Wang J, Zhang F (2019) Quinone-thioether metabolites of hydroquinone play a dual role in promoting a vicious cycle of ROS generation: in vitro and in silico insights. Arch Toxicol 93(5):1297–1309
McLemore TL, Litterst CL, Coudert BP et al (1990) Metabolic activation of 4-ipomeanol in human lung, primary pulmonary carcinomas, and established human pulmonary carcinoma cell lines. J Natl Cancer Inst 82:1420–1426
Medower C, Wen L, Johnson WW (2008) Cytochrome P450 oxidation of the thiophene-containing anticancer drug 3-[(quinolin-4-ylmethyl)-amino]-thiophene-2-carboxylic acid (4-trifluoromethoxy- phenyl)-amide to an electrophilic intermediate. Chem Res Toxicol 21(8):1570–1577
O’Donnell JP, Dalvie DK, Kalgutkar AS, Obach RS (2003) Mechanism-based inactivation of human recombinant P450 2C9 by the nonsteroidal anti-inflammatory drug suprofen. Drug Metab Dispos 31(11):1369–1377
Perlow RA, Kolbanovskii A, Hingerty BE et al (2002) DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner. J Mol Biol 321:29–47
Phillips MB, Sullivan MM, Villalta PW, Peterson LA (2014) Covalent modification of cytochrome c by reactive metabolites of furan. Chem Res Toxicol 27(1):129–135
Raucy JL, Kraner JC, Lasker JM (1993) Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit Rev Toxicol 23:1–20
Reilly CA, Henion F, Bugni TS, Ethirajan M, Stockmann C, Pramanik KC, Srivastava SK, Yost GS (2013) Reactive intermediates produced from metabolism of the vanilloid ring of capsaicinoids by P450 enzymes. Chem Res Toxicol 26(1):55–66
Ritter JK (2000) Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 129:171–193
Shimada T (2006) Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 21:257–276
Smart RC, Hodgson E (2008) Molecular and biochemical toxicology. Wiley, New York
Smith BJ, Curtis JF, Eling TE (1991) Bioactivation of xenobiotics by prostaglandin H synthase. Chem Biol Interact 79:245–264
Sridar C, D’Agostino J, Hollenberg PF (2012) Bioactivation of the cancer chemopreventive agent tamoxifen to quinone methides by cytochrome P4502B6 and identification of the modified residue on the apoprotein. Drug Metab Dispos 40(12):2280–2288
Stadtman ER (2006) Protein oxidation and aging. Free Radic Res 40:1250–1258
Stiborova M, Schmeiser HH, Frei E, Hodek P, Martinek V (2014) Enzymes oxidizing the azo dye 1- phenylazo-2-naphthol (Sudan I) and their contribution to its genotoxicity and carcinogenicity. Curr Drug Metab 15(8):829–840
Thompson DC, Eling TE (1991) Reactive intermediates formed during the peroxidative oxidation of anisidine isomers. Chem Res Toxicol 4(4):474–481
Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344
Weems JM, Lamb JG, D’Agostino J, Ding X, Yost GS (2010) Potent mutagenicity of 3-methylindole requires pulmonary cytochrome P450-mediated bioactivation: a comparison to the prototype cigarette smoke mutagens B(a)P and NNK. Chem Res Toxicol 23(11):1682–1690
Zhou S, Koh HL, Gao Y, Gong ZY, Lee EJ (2004) Herbal bioactivation: the good, the bad and the ugly. Life Sci 74(8):935–968
Zhou SF, Xue CC, Yu XQ, Wang G (2007) Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. Curr Drug Metab 8(6):526–553
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chen, CH. (2020). Reactive Intermediates Generated from Bioactivation. In: Xenobiotic Metabolic Enzymes: Bioactivation and Antioxidant Defense. Springer, Cham. https://doi.org/10.1007/978-3-030-41679-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-41679-9_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41678-2
Online ISBN: 978-3-030-41679-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)